Abstract
Metastasis is the major cause of death among cancer patients, yet early detection and intervention of metastasis could significantly improve their clinical outcomes. We have sequenced and analyzed RNA (Expression) and DNA (Mutations) from the primary tumor (PT), tumor extension (TE) and lymphatic metastatic (LM) sites of patients with clear cell renal cell carcinoma (CCRCC) before treatment. Here, we report a three-nucleotide deletion near the C-region of Plk5 that is specifically associated with the lymphatic metastasis. This mutation is un-detectable in the PT, becomes detectable in the TE and dominates the LM tissue. So while only a few primary cancer cells carry this mutation, the majority of metastatic cells have this mutation. The increasing frequency of this mutation in metastatic tissue suggests that this Plk5 deletion could be used as an early indicator of CCRCC metastasis, and be identified by low cost PCR assay. A large scale clinical trial could reveal whether a simple PCR assay for this mutation at the time of nephrectomy could identify and stratify high-risk CCRCC patients for treatments.
References
Feb 26, 2000·Carcinogenesis·J Yokota
Jun 5, 2003·Nature Reviews. Cancer·Isaiah J Fidler
Apr 9, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tim J DudderidgeGareth H Williams
Apr 29, 2006·BJU International·J James BrunoPaul Russo
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott E EggenerPaul Russo
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jun 27, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Daniel Y C Heng, Toni K Choueiri
Jan 27, 2010·Nucleic Acids Research·Zdenek AndrysikEl Mustapha Bahassi
Feb 4, 2010·PLoS Biology·Marcel A T M van VugtMichael B Yaffe
Feb 20, 2010·BMC Bioinformatics·James H BullardSandrine Dudoit
Jan 12, 2011·Nature Biotechnology·James T RobinsonJill P Mesirov
Jan 20, 2011·Molecular and Cellular Biology·Guillermo de CárcerMarcos Malumbres
Apr 19, 2011·The Journal of Urology·Simon P KimBradley C Leibovich
Sep 10, 2011·Bioinformatics·Heng Li
Feb 22, 2012·PloS One·Jian-Bing FanJiang F Zhong
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Sep 8, 2012·Genome Research·Jennifer HarrowTim J Hubbard
Dec 26, 2012·Biotechnology Advances·Zhongjun LiJiang F Zhong
May 28, 2013·Chinese Journal of Cancer·Xi ZhangJiang F Zhong
Oct 30, 2013·Genes, Chromosomes & Cancer·Lucy GossageTim Eisen
Mar 1, 2014·Balsaeng'gwa saengsig·Su-Yeon LeeKyung-Ah Lee
Oct 16, 2015·Nature·Elena PiskounovaSean J Morrison
Citations
Dec 20, 2017·Oncotarget·Qingjian WuLongkun Li
Mar 14, 2018·World Journal of Stem Cells·Shengwen Calvin Li, Mustafa H Kabeer
Sep 22, 2020·World Journal of Stem Cells·Lisa X Lee, Shengwen Calvin Li
Nov 13, 2019·Transplantation Proceedings·Cheng ZhangXi Zhang
Feb 10, 2021·Journal of Cellular and Molecular Medicine·Wen LiFan Cheng
Dec 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tairine Zara LopesMarilia Freitas Calmon
Feb 20, 2020·Artificial Cells, Nanomedicine, and Biotechnology·Ludong Zhang, Ya Guo
May 12, 2021·Cancer Medicine·Dingwen GuiYunfei Zhao
Jun 3, 2021·Cells·Monika KressinKlaus Strebhardt